Drug Discovery
Mabwell Starts Phase Ib/II Trial for Nectin-4 ADC with PD-1 Inhibitor
The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...
September 29, 2023 | News
SGC and HitGen Partner for DNA-Encoded Drug Discovery
HitGen will utilize its DNA-encoded library (DEL) technology platform, specifically OpenDEL™, to screen under-represented targets chosen by SGC. &nbs...
September 29, 2023 | News
Everest Medicines Gets Taiwan Approval for XERAVA® in Treating Intra-Abdominal Infections
"The NDA approval of XERAVA® in Taiwan marks an important step towards bringing this novel, critical therapy for complicated intra-abdominal ...
September 28, 2023 | News
Ascletis Completes Enrollment for Glioblastoma Treatment Trial
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...
September 27, 2023 | News
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology
"We're thrilled to strengthen our existing suite of patents," said Peter Choo, Chairman of CytoMed. "Now this novel iPSC-based technology has been gra...
September 26, 2023 | News
MicuRx Receives FDA QIDP and Fast Track Designation for Contezolid & Acefosamil
The QIDP and Fast Track designations were created as part of the Food and Drug Administration Safety and Innovation Act, FDASIA (June 2012), Titl...
September 25, 2023 | News
Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to end-to-end AI platform ca...
September 21, 2023 | News
Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets
"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...
September 21, 2023 | News
Caliway Completes Recruitment for CBL-514 Cellulite Treatment Phase 2 Study
The CBL-0201EFP Phase 2-stage 2 study is an open-label trial that will evaluate the efficacy, safety, and tolerability of CBL-514 in treating subjects with...
September 20, 2023 | News
Kyrgyzstan, Ukraine, and Uzbekistan Revise TB Guidelines for Three-Drug Regimen
Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their National Tuberculosis (TB) Clinic...
September 19, 2023 | News
Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...
September 18, 2023 | News
Exelixis and Insilico Medicine Ink Global License Deal for ISM3091, a Leading USP1 Inhibitor
— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1 identified through Insilico Medicine's artificial int...
September 14, 2023 | News
Metabolon Debuts Stress Discovery Panel for Biomarker Detection
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, diagnostic, therapeutic development, and preci...
September 13, 2023 | News
Waters Introduces Simplified Solutions for Biologic Drug Analysis
Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and...
September 13, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
